Introduction
The evidence for a role for prostaglandins (PGs) in the implantation process in several species is increasing (Lau, Saksena & Chang, 1973; Saksena, Lau & Chang, 1976;  Kennedy, 1977 Kennedy, , 1979  Biggers, Leonov, Baskar & Fried, 1978; Evans & Kennedy, 1978; Hoffman, 1978; Hoffman, DiPietro & McKenna, 1978; Oettel, Koch, Jurishko & Schubert, 1979; Holmes & Gordashko, 1980 ;  Kennedy, Barbe & Evans, 1980 ;  Biggers, Baskar & Torchiana, 1981 ; Phillips & Poyser 1981 ).
Implantation of blastocysts can be blocked by indomethacin treatment in mice (Lau et al, 1973 ; Saksena et al., 1976) and in rats (Kennedy, 1977; Phillips & Poyser, 1981) but not in rabbits rats . These findings led Kennedy (1979 Kennedy ( ,1980 to conclude that PGs of the E series were likely to be the key mediators of increased vascular permeability at the implantation site. Specific binding of PGE-2 to endometrial membranes of stromal, but not epithelial cells, from ovariectomized rats sensitized for the decidual cell reaction, has now been demonstrated (Kennedy, Martel & Psychoyos, 1983) . Similarly, in rabbits endometrial epithelial cells on Day 6 of pregnancy do not bind PGs specifically, but exhibit non-saturable uptake (Jones & Harper, 1983) .
However, the source of the PGs during the implantation process has not been determined. Unlike the rat (Kennedy & Armstrong, 1981) and mouse (Racowsky & Biggers, 1983) , rabbit blastocysts contain, just before implantation, large quantities of PGE and PGF, some of which may be synthesized by the blastocysts themselves (Dickmann & Spilman, 1975; Dey, Chien, Cox & Crist, 1980; Sharma, 1980; Harper, Norris & Rajkumar, 1983; Racowsky & Biggers, 1983 ). An important question is whether, in the rabbit, it is the PGs from the blastocyst or the endometrium which trigger the capillary permeability changes at the implantation site. The present experiments were therefore designed to inhibit PG synthesis in donor and recipient animals, and to examine the effect of such inhibition in blastocysts and endometrium on subsequent implantation by means of a blastocyst transfer technique. A preliminary report has been published (Snabes & Harper, 1984) .
Materials and Methods
Mature, New Zealand White-Cambridge-strain female rabbits (> 3-0 kg) were caged individually in a controlled environment with a photoperiod of 14 h light per 24 h. They were fed with 170 g of rabbit pellets per day and water was supplied ad libitum. The rabbits were induced to superovulate using the method of Mukherjee, Dey, Gupta, Ramadoss & Dickmann (1978) . Donor (Brinster, 1963) with 20% of decomplemented (56°C for 30 min) rabbit serum added. Blastocysts were transferred within 20 min of recovery (135-139 h after hCG) into the uterine lumina of oil-or indomethacin-treated recipients laparotomized under general anaesthesia with pentobarbitone sodium. A 5-mm incision was made in the uterine wall near the uterotubal junction, through which a teflon tube (5 cm long; 5 mm o.d.; 3 mm i.d.) fitted to a 500 µ Hamilton syringe (Hamilton Company, Whittier, CA) containing the blastocysts was introduced. After expulsion of the contents of the tube and its with¬ drawal, the uterine incision was closed with two small stitches. The peritoneum, abdominal wall and skin were closed using 2-0 silk. After recovery, the animals were returned to their original cages. The design of the experiment was such that half of the blastocysts from any one donor (oil-or indomethacin-treated) were transferred into an oil-treated recipient and the rest into an indo¬ methacin-treated recipient. (Sokal & Rohlf, 1969 (Dickmann & Spilman, 1975; Dey et al., 1980; Sharma, 1980; Harper et al., 1983 ; Racowsky & Biggers, 1983) , and can also, to some extent, synthesize PGs de novo (Dey étal., 1980; Harper et al., 1983; Racowsky & Biggers, 1983) , it is possible that it is these blastocyst PGs that are responsible for the prostaglandin-mediated actions locally induced at the implanta¬ tion site. The more rapid release of PGE-2 compared to that of PGF-2a on Days 5-6-8, and on Day 6-8 only compared to that of itself on Days 5 and 6 of pregnancy (Jones & Harper, 1984) , suggests a possible differential release of PGE-2 (the PG implicated in the local changes of vascular permeability ) during the period when such changes at the implantation site are first observed . If this were the case, it seems possible that exposure of blastocysts to a milieu in which PG synthesis by both endometrium and blastocysts was inhibited up to the time of transfer at Day 6 of pregnancy should render the blastocysts deficient in PGs and unable to induce the prostaglandin-induced changes at the implantation site in untreated recipients. We know from other experiments that the treatment regimen with indomethacin (given to the donors) reduces PG levels in Day-6 blastocysts from the usual 0-67 + 0-45 ng PGF and 0-21 + 005 ng PGE/blastocyst (n = 3 experiments with 10 blastocysts pooled from 3 rabbits) to 0-03 + 003 ng PGF and no detectable PGE/blastocyst (n = 3 experiments with 10 blastocysts pooled from 3 rabbits) (M. A. Jones, C. J. Norris & M. J. K. Harper, unpublished) . Most of the PG in the blasto¬ cyst is found in the blastocoelic fluid (88% of PGF-2a and 92% of PGE-2), where it is not subjected to metabolism (Jones & Harper, 1984) , and therefore, theoretically, is easily released to the exterior when properly stimulated. Indeed, during in-vitro culture, 6-day blastocysts do release substantial quantities of radioimmunoassayable PGF and PGE into the culture medium-0-18 + 0-05 and 0-07 + 0-01 ng/blastocyst, respectively, during a 1-h period .
We feel certain, therefore, that the blastocysts from the indomethacin-treated rabbits contained essentially no prostaglandins at the time of transfer to recipients. The recipients were treated with two separate protocols. In Exp. 1, the indomethacin treatment was continued after transfer every 6 h up until the time of implantation. This dose was clearly toxic to the rabbits, because 6 out of 8 died after Day 9 of pregnancy. Therefore, the almost complete failure of either oil-or indomethacintreated blastocysts to implant in these animals may not have been due to inhibition of endometrial prostaglandins, but to generalized toxicity. Indomethacin has also been reported to have other pharmacological actions (Bito, Davson & Salvador, 1976) . However, none of these deaths occurred until well after actual implantation, and so this toxic effect was clearly not immediate. In addition, implantation of oil-or indomethacin-treated blastocysts in oil-treated recipients was completely normal, the success rate being greater than in previously published results (Chang, 1950) . The mean diameters of the implantation sites on Days 10 and 17 were not different from previously published data (Adams, 1960) , irrespective of the source of the blastocysts. In this first experiment, transfers were done when blastocysts were only a little more than 5^days old, so it could be argued that there was sufficient time for them to sequester PGs from uterine fluid and then release them at the critical time 12-24 h later. In other experiments, we have found that blastocysts must be in the uterus for more than 6 h but not more than 20 h to induce the uterine blueing reaction at Day 6-8 of pregnancy in rabbits.
To obviate the problems of toxicity and to reduce the time for recovery of blastocyst PG levels, in Exp. 2 indomethacin treatment ceased after transfer and blastocysts were transferred at 6 days of pregnancy. The results for blastocysts transferred from oil-or indomethacin-treated donors to oiltreated recipients were similar to those in Exp. 1. Blastocyst implantation and development were not influenced by the treatment of the donors. In contrast to Exp. 1, however, blastocyst implanta¬ tion in indomethacin-treated recipients was completely normal, as was embryonic growth to Day 10. Furthermore, no recipients died.
These results led to the conclusion that indomethacin treatment which affects the endometrium must be continued to the time of implantation to be effective. It is still not certain that the blasto¬ cysts also may not have had time between the time of transfer (Day 6) and Day 6-5 to synthesize and/or sequester sufficient prostaglandins and then to release them locally to initiate the vascular permeability changes normally seen at Day 6-5 of pregnancy. However, El-Banna (1980) has reported that, in rabbits, administration of 8 mg indomethacin/kg s.e. twice daily on Days 5 and 6, but not on Day 6 only or on the evening of Day 5 and morning of Day 6 only, was able to reduce the percentage of blastocysts implanting. Given these results and those of the present experiments, the balance of probabilities would suggest that it is the endometrium rather than the blastocysts which is responsible for the production of the prostaglandins implicated in the implantation process; the mechanism localizing this action to the area adjacent to the blastocyst remains obscure.
